Affinity Asset Advisors, LLC - 16 Oct 2025 SCHEDULE 13G Report for SUTRO BIOPHARMA, INC. Common Stock, par value $0.001 per share (STRO)

Filing Manager
Affinity Asset Advisors, LLC
Reporting Manager
Affinity Healthcare Fund, LP
Security
SUTRO BIOPHARMA, INC. Common Stock, par value $0.001 per share
Symbol
STRO
Shares outstanding
84,733,230 shares
Disclosed Ownership
6,583,772 shares
Ownership
7.8%
Form type
SCHEDULE 13G
Filing time
23 Oct 2025, 16:07:17 UTC
Date of event
16 Oct 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Affinity Healthcare Fund, LP 7.8% 6,583,772 0 6,583,772 /s/ Andrew Weinstein Andrew Weinstein, Chief Financial Officer and Chief Compliance Officer
Affinity Asset Advisors, LLC 7.8% 6,583,772 0 6,583,772 /s/ Andrew Weinstein Andrew Weinstein, Chief Financial Officer and Chief Compliance Officer